Discovery of N-substituted pyridinones as potent and selective inhibitors of p38 kinase
Journal Article
·
· Bioorg. Med. Chem. Lett.
The identification and evolution of a series of potent and selective p38 inhibitors is described. p38 inhibitors based on a N-benzyl pyridinone high-throughput screening hit were prepared and their SAR explored. Their design was guided by ligand bound co-crystals of p38{alpha}. These efforts resulted in the identification of 12r and 19 as orally active inhibitors of p38 with significant efficacy in both acute and chronic models of inflammation.
- Research Organization:
- Argonne National Laboratory (ANL)
- Sponsoring Organization:
- USDOE
- OSTI ID:
- 1006145
- Journal Information:
- Bioorg. Med. Chem. Lett., Journal Name: Bioorg. Med. Chem. Lett. Journal Issue: (20) ; 10, 2009 Vol. 19; ISSN 0960-894X
- Country of Publication:
- United States
- Language:
- ENGLISH
Similar Records
5-Amino-pyrazoles as potent and selective p38[alpha] inhibitors
Substituted N-aryl-6-pyrimidinones: A new class of potent, selective, and orally active p38 MAP kinase inhibitors
Discovery and Lead-Optimization of 4,5-Dihydropyrazoles as Mono-Kinase Selective, Orally Bioavailable and Efficacious Inhibitors of Receptor Interacting Protein 1 (RIP1) Kinase
Journal Article
·
Mon Feb 06 23:00:00 EST 2012
· Bioorg. Med. Chem. Lett.
·
OSTI ID:1025635
Substituted N-aryl-6-pyrimidinones: A new class of potent, selective, and orally active p38 MAP kinase inhibitors
Journal Article
·
Mon Feb 27 23:00:00 EST 2012
· Bioorg. Med. Chem. Lett.
·
OSTI ID:1026534
Discovery and Lead-Optimization of 4,5-Dihydropyrazoles as Mono-Kinase Selective, Orally Bioavailable and Efficacious Inhibitors of Receptor Interacting Protein 1 (RIP1) Kinase
Journal Article
·
Mon Apr 22 20:00:00 EDT 2019
· Journal of Medicinal Chemistry
·
OSTI ID:1544867